f f f f f f
Edition by Elena Bablenis Haveles
f f f f f
Complete Test Bank
f f
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription
f f f f f f f f f
Writing
f
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
f f f f f f f f
MULTIPLE CHOICE f
1. Knowledge of pharmacology aids the dental professional in f f f f f f f
a. obtaining a patient’s health history. f f f f
b. administering drugs in the office. f f f f
c. handling emergency situations. f f
d. selection of a nonprescription medication. f f f f
e. All of the above. f f f
ANS: E f
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
f f f f f f f f f f f f f f f f f
pharmacology helps in understanding and interpreting patients’ responses to health history questions.
f f f f f f f f f f f f
Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
f f f f f f f f f f f f f f
administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
f f f f f f f f f f f f f f f f
knowledge of pharmacology is of great help, especially because a rapid response is sometimes
f f f f f f f f f f f f f f
required. A clear understanding of the concepts of drug action, drug handling by the body, and drug
f f f f f f f f f f f f f f f f f
interactions will allow the dental practitioner to make proper judgments and grasp the concepts relevant
f f f f f f f f f f f f f f f
to new drug therapies on the market.
f f f f f f f
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
f f f f f f f f f f f f f
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist
f f f f f f f f f f f f f
(Nonprescription Medication) | pp. 2-3
f OBJ: 1 f f f f
TOP: NBDHE, 6.0. Pharmacology
f f f
2. Which of the following statements is true regarding planning appointments?
f f f f f f f f f
a. Whether or not patients are taking medication for systemic diseases is of little
f f f f f f f f f f f f
consequence in the dental office. f f f f
b. Asthmatic patients should have dental appointments in the morning. f f f f f f f f
c. Diabetic patients usually have fewer problems with a morning appointment
f f f f f f f f f
compared with afternoon appointments.
f f f f
d. Both B and C are true. f f f f f
ANS: D f
Asthmatic patients who experience dental anxiety should schedule their appointments when they are not
f f f f f f f f f f f f f
rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems
f f f f f f f f f f f f f f f
with a morning appointment. Patients taking medication for systemic diseases may require special
f f f f f f f f f f f f f
handling in the dental office.
f f f f f
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3
f f f f f f f f f f
OBJ: 1
f TOP: NBDHE, 6.0. Pharmacology
f f f f
,3. Nutritional or herbal supplements f f f
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states.
f f f f f f f f f f f
b. are not drugs. f f
c. can cause adverse effects. f f f
d. will not interact with other drugs the patient may be taking.
f f f f f f f f f f
ANS: C f
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional
f f f f f f f f f f f f f f
or herbal supplements do not carry FDA approval for treating disease states. These supplements are
f f f f f f f f f f f f f f f
drugs and can cause adverse effects and interact with different drugs.
f f f f f f f f f f f
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | p. 3
f f f f f f f f f f f f
OBJ: 1
f TOP: NBDHE, 6.0. Pharmacology
f f f f
4. Which type of drug name usually begins with a lowercase letter?
f f f f f f f f f f
a. Brand name f
b. Code name f
c. Generic name f
d. Trade name f
ANS: C f
Before any drug is marketed, it is given a generic name that becomes the ―official‖ name of the drug.
f f f f f f f f f f f f f f f f f f
Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the
f f f f f f f f f f f f f f f f f
name is not capitalized. The brand name is equivalent to the trade name and is capitalized. Although the
f f f f f f f f f f f f f f f f f f
brand name is technically the name of the company marketing the product, this term is often used
f f f f f f f f f f f f f f f f f
interchangeably with the trade name. The code name is the initial term used within a pharmaceutical
f f f f f f f f f f f f f f f f
company to refer to a drug while it is undergoing investigation and is often a combination of capital
f f f f f f f f f f f f f f f f f f
letters and numbers, the letters representing an abbreviation of the company name.
f f f f f f f f f f f f
DIF: Comprehension REF: Drug Names | p. 4 f f f f f
OBJ: 3
f TOP: NBDHE, 6.0. Pharmacology
f f f f
5. A drug’s generic name is selected by the
f f f f f f f
a. pharmaceutical company manufacturing it. f f f
b. Food and Drug Administration (FDA). f f f f
c. U.S. Adopted Name Council. f f f
d. Federal Patent Office. f f
ANS: C f
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
f f f f f f f f f f f f f f f f f
Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
f f f f f f f f f f f f f f f f f
company manufacturing the drug clearly has an influence on the generic name given its drug, but the
f f f f f f f f f f f f f f f f f
final decision is not the company’s.
f f f f f f
DIF: Recall REF: Drug Names | p. 4 f f f f f OBJ:
f3 TOP: NBDHE, 6.0. Pharmacology
f f f f
6. Which of the following is true concerning generic and trade names of drugs?
f f f f f f f f f f f f
a. A drug may only have one generic name and one trade name.
f f f f f f f f f f f
, b. A drug may only have one generic name, but it may have several trade names.
f f f f f f f f f f f f f f
c. A drug may have several generic names, but it may only have one trade name.
f f f f f f f f f f f f f f
d. A drug may have several generic names and several trade names.
f f f f f f f f f f
ANS: B f
Each drug has only one generic name but may have several trade names. For each drug, there is only one
f f f f f f f f f f f f f f f f f f f
generic name. It is not capitalized, and it becomes the ―official‖ name of the drug. The pharmaceutical
f f f f f f f f f f f f f f f f f
company discovering the drug gives the drug a trade name. The trade name is protected by the Federal
f f f f f f f f f f f f f f f f f f
Patent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the
f f f f f f f f f f f f f f f f f
brand name is technically the name of the company marketing the product, it is often used
f f f f f f f f f f f f f f f f
interchangeably with the trade name.
f f f f f
DIF: Comprehension REF: Drug Names | p. 4 f f f f f
OBJ: 3
f TOP: NBDHE, 6.0. Pharmacology
f f f f
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent or
f f f f f f f f f f f f f
therapeutically equivalent are said to differ in
f f f f f f f
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. f
ANS: C f
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
f f f f f f f f f f f f
products are said to differ in their bioavailability. The potency of a drug is a function of the amount of
f f f f f f f f f f f f f f f f f f f f
drug required to produce an effect. The efficacy is the maximum intensity of effect or response that can
f f f f f f f f f f f f f f f f f f
be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental
f f f f f f f f f f f f f f f f f f f f
animals divided by the effective dose for 50% of the experimental animals. If the value of the
f f f f f f f f f f f f f f f f f
therapeutic index is small, toxicity is more likely.
f f f f f f f f
DIF: Recall REF: Drug Names (Drug Substitution) | p. 5 f f f f f f f
OBJ: 4
f f TOP: NBDHE, 6.0. Pharmacology f f f
8. How many years must pass after a drug patent expires before other drug companies can market the
f f f f f f f f f f f f f f f f
same compound as a generic drug?
f f f f f f
a. 20 years f
b. 17 years f
c. 7 years f
d. 0 years f
ANS: D f
Once a drug patent expires, competing companies may immediately market the same compound in
f f f f f f f f f f f f f
generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The trade
f f f f f f f f f f f f f f f f
name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus the
f f f f f f f f f f f f f f f f f f f
patent term extensions.
f f f
DIF: Application REF: Drug Names (Drug Substitution) | p. 5 f f f f f f f
OBJ: 4
f f TOP: NBDHE, 6.0. Pharmacology f f f